We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Parkinson's Disease Linked to Malfunctions in Mitochondrial Fission and Fusion

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Image: Two mitochondria from mammalian tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
Image: Two mitochondria from mammalian tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
Neurodegenerative diseases researchers in the United Kingdom have found that development of Parkinson's disease (PD) is linked to malfunctions in the processes that regulate mitochondrial fission and fusion.

Mitochondrial dysfunction has been reported in both the familial and sporadic forms of PD. Mitochondria are constantly fusing and dividing with each other, forming large, reticular networks. To study the molecular regulators of these processes, investigators at Plymouth University (United Kingdom) used two complementary mouse models of mitochondrial impairments as seen in PD: the PTEN-induced putative kinase-1 deletion (PINK1−/−) and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse models.

They reported in the November 5, 2014, online edition of the journal Nature Communications that blocking the action of the mitochondrial fission protein GTPase dynamin-related protein-1 (Drp1) using either gene-therapy or a chemical approach reduced both cell death and deficits in dopamine release, which effectively reversed PD progression in both models.

Drp1 is a member of the Dynamin enzyme family of large GTPases. Drp1 controls the final part of mitochondrial fission, pinching off the membrane stalk between two forming daughter mitochondria. Several studies have indicated that Drp1 is essential for proper embryonic development, and that in humans, loss of Drp1 function affects brain development and is also associated with early mortality.

Senior author Dr. Kim Tieu, associate professor of clinical neurobiology at Plymouth University, said, "Our findings show exciting potential for an effective treatment for PD and pave the way for future in-depth studies in this field. It is worth noting that other researchers are also targeting this mitochondrial fission/fusion pathway as potential treatments for other neurological diseases such as Alzheimer's disease, Huntington's disease and Amyotrophic Lateral Sclerosis."

Related Links:

Plymouth University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.